Close Menu

Immunoassays

News on immunoassay systems and applications.

The firm is also targeting a new market for oral fluid-based tests for drugs of abuse, projecting future growth due to new federal regulations.

The firm's diagnostics revenues decreased 9 percent to $33.4 million, and life sciences revenues increased 7 percent to $17.4 million.

OraSure will purchase Houston-based Diversigen, a microbiome and metagenomics consulting, sequencing, and data analysis service provider.

The acquisition of immunohistochemistry services provider QualTek will augment Discovery's existing histopathology services, the company said.

The firm plans to launch 10 new products next year, but analysts were cautious about Quidel's prospects moving forward.  

In a cartoon, Vox explores the lack of women among this year's winners of the Nobel Prize.

Nature Biotechnology discusses promising early results from two clinical trials of CRISPR-based therapy for β-thalassemia and sickle cell disease.

In Cell this week: analysis of tissue clones, metagenomic studies of ocean water samples, and more.

Forensic genetic firm Verogen has bought the genetic genealogy site GEDmatch.